|
Guardant Health
guardant360 platform Guardant360 Platform, supplied by Guardant Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/guardant360+platform/pmc13068569-50-6-9?v=Guardant+Health Average 86 stars, based on 1 article reviews
guardant360 platform - by Bioz Stars,
2026-07
86/100 stars
|
Buy from Supplier |
|
Guardant Health
next-generation sequencing–based 74-gene guardant360 platform Next Generation Sequencing–Based 74 Gene Guardant360 Platform, supplied by Guardant Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/guardant360+platform/pmc12260505-146-10-13?v=Guardant+Health Average 90 stars, based on 1 article reviews
next-generation sequencing–based 74-gene guardant360 platform - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Guardant Health
guardant360® platform Guardant360® Platform, supplied by Guardant Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/guardant360+platform/pmc10915757-139-30-32?v=Guardant+Health Average 90 stars, based on 1 article reviews
guardant360® platform - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Guardant Health
guardant360 cdx platform ![]() Guardant360 Cdx Platform, supplied by Guardant Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/guardant360+platform/pmc10957471-296-12-15?v=Guardant+Health Average 90 stars, based on 1 article reviews
guardant360 cdx platform - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
Journal: Nature Medicine
Article Title: Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
doi: 10.1038/s41591-024-02824-y
Figure Lengend Snippet: a , Heatmap of genetic alterations detected using Guardant360 CDx. b , Progression-free survival and overall survival according to the presence of genetic alterations in the Wnt/β-Catenin pathway, evaluated by circulating tumor DNA analysis. Two-sided Log-rank test was used for comparison.
Article Snippet: Using baseline samples of all 42 patients, ctDNA was analyzed using the
Techniques: Comparison